NASDAQ:CREX - Nasdaq - US22530J3095 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 48.30M | 50.85M | 45.17M | 43.35M | 18.44M | |||
Cost Of Goods | 25.60M | 26.84M | 22.98M | 25.61M | 10.08M | |||
Gross Profit | 22.70M | 24.01M | 22.18M | 17.74M | 8.36M | |||
Operating Expenses | 22.41M | 23.07M | 20.84M | 19.63M | 10.39M | |||
Research and Development | N/A | N/A | 1.57M | 1.25M | 550.00K | |||
Selling, General, and Administrative Expenses | 22.41M | 23.07M | 16.04M | 15.54M | 8.47M | |||
Operating Income | 292.00K | 938.00K | 1.35M | -1.89M | -2.04M | |||
Interest Income/Expense | -3.65M | -3.38M | -4.41M | 6.23M | -810.00K | |||
Other Income/Expense | 58.00K | 102.00K | 211.00K | -350.00K | -530.00K | |||
Non Recurring Items | N/A | -1.06M | 0.00 | -2.04M | 3.62M | |||
Income Before Taxes | 165.00K | -3.40M | -2.85M | 1.96M | 250.00K | |||
Income Tax | 196.00K | 106.00K | 83.00K | 80.00K | 20.00K | |||
Net Income | -31.00K | -3.51M | -2.94M | 1.88M | 230.00K | |||
EBITDA | 4.72M | 5.02M | 4.57M | 940.00K | -680.00K | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.00 | -0.34 | -0.35 | 0.28 | 0.06 | |||
Non GAAP EPS | 0.46 | -0.33 | -0.35 | N/A | N/A | |||
Statistics | ||||||||
Gross Profit Margin | 47.00% | 47.22% | 49.11% | 40.92% | 45.34% | |||
Profit Margin | -0.06% | -6.90% | -6.50% | 4.34% | 1.25% | |||
Operating Profit Margin | 0.60% | 1.84% | 2.98% | -4.36% | -11.06% |
All data in USD